Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study

MLA

Lindsay M. Morton, et al. “Risk of Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia after Childhood Cancer: A Population-Based Study.” Leukemia, vol. 33, July 2019, pp. 2947–78. EBSCOhost, https://doi.org/10.1038/s41375-019-0520-y.

APA

Lindsay M. Morton, Martha S. Linet, Stephen J. Chanock, Pragati Advani, Clara J K Lam, Byron S. Sigel, Margaret A. Tucker, Sara J. Schonfeld, Graça M. Dores, & Rochelle E. Curtis. (2019). Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study. Leukemia, 33, 2947–2978. https://doi.org/10.1038/s41375-019-0520-y

Chicago

Lindsay M. Morton, Martha S. Linet, Stephen J. Chanock, Pragati Advani, Clara J K Lam, Byron S. Sigel, Margaret A. Tucker, Sara J. Schonfeld, Graça M. Dores, and Rochelle E. Curtis. 2019. “Risk of Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia after Childhood Cancer: A Population-Based Study.” Leukemia 33 (July): 2947–78. doi:10.1038/s41375-019-0520-y.